跳至主要内容
临床试验/CTRI/2017/03/007978
CTRI/2017/03/007978已完成4 期

The efficacy of pregabalin for prevention of etomidate-induced myoclonus: a prospective, randomized, placebo-controlled, double-blind study

Apollo Hospitals Bilaspur0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.ASA grade I and II,
  • 2.non hypertensive and non diabetic
  • 3.scheduled for surgery under general anesthesia

排除标准

  • 1.patients with known sensitivity to pregabalin,
  • 2.seizure disorders, who were taking pregabalin or gabapentin,
  • 3.history of drug or alcohol abuse,
  • 4.history of chronic pain or daily intake of analgesics,
  • 5.pregnant or breast-feeding females,
  • 6.uncontrolled medical disease (diabetes mellitus and hypertension)
  • 7.impaired kidney or liver functions and
  • 8.psychiatric patients

研究者

相似试验

Prevention of etomidate induced myoclonus by use of... | 临床试验